News

Alpha Tau, Samsung Medical Center Partner for Potential Pancreatic Cancer Trial

Alpha Tau has partnered with Samsung Medical Center to explore a potential clinical trial of its Alpha DaRT cancer therapy in pancreatic cancer patients in South Korea, which could expand its pancreatic cancer programme to six countries.